Phase 2a study demonstrated rapid and substantial decrease in depressive symptoms SPN-820 was well-tolerated with few adverse events SPN-820 is a novel, first-in-class intracellular modulator of mTORC ...
Phase 2a study demonstrated rapid and substantial decrease in depressive symptoms SPN-820 was well-tolerated with few adverse events SPN-820 is a novel, first-in-class intracellular modulator of ...
Enterprise AI adoption is still in its exploration stages, but companies are finding innovative ways to leverage their GPU investments beyond AI applications and reaping good results, according to a ...
Following successful Phase 1b completion, Clarametyx is initiating the Phase 2a portion to assess CMTX-101 as an adjunct to standard of care for chronic ...
Celebrities can have huge influence and reach enormous audiences. That's why Kamala Harris was happy to recently gain the endorsement of musician Taylor Swift.